| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | L8LE0L691T |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Ig epsilon chain C region inhibitor | PubMed |
| Primary Target | |
|---|---|
| immunoglobulin heavy constant epsilon |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Urticaria | 3 | D014581 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
| Pemphigoid, Bullous | 2 | D010391 | ClinicalTrials |
| Peanut Hypersensitivity | 2 | D021183 | ClinicalTrials |
| Hypersensitivity | 1 | D006967 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1322627-61-1 |
| ChEMBL | CHEMBL2109457 |
| FDA SRS | L8LE0L691T |
| Guide to Pharmacology | 8997 |
CONTENTS